Akums Drugs & Pharmaceuticals Shareholding

Akums Drugs & Pharmaceuticals Ltd Shareholding Pattern

The Akums Drugs & Pharmaceuticals Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Akums Drugs & Pharmaceuticals Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Akums Drugs & Pharmaceuticals Ltd (NSE: AKUMS, BSE: 544222) operates in the Health technology sector and Biotechnology industry. Monitoring the Akums Drugs & Pharmaceuticals Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Akums Drugs & Pharmaceuticals Ltd Shareholding Pattern (Latest)

The latest Akums Drugs & Pharmaceuticals Ltd shareholding for Mar 2026 is:

• Promoters: 75.26%
• FII: 1.37%
• DII: 14.35%
• Public: 9.02%
• Government: 0%

Promoter holding in Akums Drugs & Pharmaceuticals Ltd remains stable, reflecting consistent long-term commitment.

Akums Drugs & Pharmaceuticals Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Akums Drugs & Pharmaceuticals Ltd.

• Mar 2026: 75.26%
• Dec 2025: 75.26%
• Sept 2025: 75.26%
• Jun 2025: 75.26%
• Mar 2025: 75.26%

Promoter stake remains largely stable, showing consistent ownership structure.

Akums Drugs & Pharmaceuticals Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Akums Drugs & Pharmaceuticals Ltd.

• Mar 2026: 1.37%
• Dec 2025: 1.15%
• Sept 2025: 2.28%
• Jun 2025: 4.24%
• Mar 2025: 5.77%

FII holding in Akums Drugs & Pharmaceuticals Ltd has increased recently, indicating rising foreign investor interest.

Akums Drugs & Pharmaceuticals Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Mar 2026: 14.35%
• Dec 2025: 14.40%
• Sept 2025: 9.28%
• Jun 2025: 8.85%
• Mar 2025: 7.40%

DII holdings remain stable, reflecting steady institutional participation.

Akums Drugs & Pharmaceuticals Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Mar 2026: 9.02%
• Dec 2025: 9.19%
• Sept 2025: 13.19%
• Jun 2025: 11.65%
• Mar 2025: 11.58%

Public holding remains stable with consistent retail participation.

Akums Drugs & Pharmaceuticals Ltd Government Holding

Government holding in Akums Drugs & Pharmaceuticals Ltd currently stands at 0%.

Akums Drugs & Pharmaceuticals Ltd operates without significant government ownership.

Akums Drugs & Pharmaceuticals Ltd Shareholding Analysis Summary

The Akums Drugs & Pharmaceuticals Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Akums Drugs & Pharmaceuticals Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.

Regular monitoring of the Akums Drugs & Pharmaceuticals Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.